Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 71.08% is 115% above its 5-year average of -463.18%, near the high end of its 5-year range (-13148.14%–255.21%).
42.44% above its 12-month average of 49.90%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 61.00%.
NET PROFIT MARGIN
71.08%
NET PROFIT MARGIN AVG TTM
49.90%
NET PROFIT MARGIN AVG 3Y
-115.88%
NET PROFIT MARGIN AVG 5Y
-463.18%
NET PROFIT MARGIN AVG 10Y
-2619.03%
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+42.44%
CURRENT VS 3Y AVG
+161.34%
CURRENT VS 5Y AVG
+115.35%
CURRENT VS 10Y AVG
+102.71%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 340 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Ascendis Pharma A/S
Market Cap
$14.16B
Net Profit Margin
71.08%
TTM Avg
49.90%
3Y Avg
-115.88%
5Y Avg
-463.18%
Market Cap
$14.64B
Net Profit Margin
-17.77%
TTM Avg
-60.53%
3Y Avg
-62.93%
5Y Avg
-77.31%
Market Cap
$14.79B
Net Profit Margin
35.33%
TTM Avg
28.88%
3Y Avg
23.04%
5Y Avg
19.31%
Market Cap
$14.97B
Net Profit Margin
-5.96%
TTM Avg
-1.67%
3Y Avg
5.09%
5Y Avg
7.31%
Market Cap
$13.19B
Net Profit Margin
6.61%
TTM Avg
16.89%
3Y Avg
20.26%
5Y Avg
23.62%
Market Cap
$15.24B
Net Profit Margin
17.26%
TTM Avg
12.25%
3Y Avg
14.36%
5Y Avg
15.15%
Market Cap
$12.95B
Net Profit Margin
-97.64%
TTM Avg
-193.35%
3Y Avg
-1980.08%
5Y Avg
-2361.16%
Market Cap
$12.89B
Net Profit Margin
3.99%
TTM Avg
6.17%
3Y Avg
6.60%
5Y Avg
6.82%
Market Cap
$12.52B
Net Profit Margin
-9.27%
TTM Avg
-7.30%
3Y Avg
-3.29%
5Y Avg
1.14%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Ascendis Pharma A/S (ASND) | $14.16B | 71.08% | 49.90% | -115.88% | -463.18% |
| Tempus AI, Inc. (TEM)vs › | $14.64B | -17.77% | -60.53% | -62.93% | -77.31% |
| Exelixis, Inc. (EXEL)vs › | $14.79B | 35.33% | 28.88% | 23.04% | 19.31% |
| Charles River Laboratories International, Inc. (CRL)vs › | $14.97B | -5.96% | -1.67% | 5.09% | 7.31% |
| Corcept Therapeutics Incorporated (CORT)vs › | $13.19B | 6.61% | 16.89% | 20.26% | 23.62% |
| Solventum Corporation (SOLV)vs › | $15.24B | 17.26% | 12.25% | 14.36% | 15.15% |
| BridgeBio Pharma, Inc. (BBIO)vs › | $12.95B | -97.64% | -193.35% | -1980.08% | -2361.16% |
| ICON Public Limited Company (ICLR)vs › | $12.89B | 3.99% | 6.17% | 6.60% | 6.82% |
| Baxter International Inc. (BAX)vs › | $12.52B | -9.27% | -7.30% | -3.29% | 1.14% |
| Penumbra, Inc. (PEN)vs › | $12.49B | 10.67% | 6.92% | 5.54% | 3.35% |
Operating Margin
-18.9%
Net Profit Margin
71.1%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 61.00% |
| 2026-03-31 | 255.21% |
| 2025-12-31 | -13.56% |
| 2025-09-30 | -28.55% |
| 2025-06-30 | -24.58% |
| 2025-03-31 | -93.73% |
| 2024-12-31 | -22.12% |
| 2024-09-30 | -171.52% |
| 2024-06-30 | -303.85% |
| 2024-03-31 | -136.65% |
| 2023-12-31 | -63.09% |
| 2023-09-30 | -337.73% |
| 2023-06-30 | -256.23% |
| 2023-03-31 | -330.21% |
| 2022-12-31 | -905.91% |
| 2022-09-30 | -1105.00% |
| 2022-06-30 | -1320.11% |
| 2022-03-31 | -1837.99% |
| 2021-12-31 | -2165.86% |
| 2021-09-30 | -7219.05% |
| 2021-06-30 | -13148.14% |
| 2021-03-31 | -8417.16% |
| 2020-12-31 | -25974.77% |
| 2020-09-30 | -4415.71% |
| 2020-06-30 | -6610.86% |
| 2020-03-31 | -2845.71% |
| 2019-12-31 | -3205.50% |
| 2019-09-30 | -1119.62% |
| 2019-06-30 | -1834.44% |
| 2019-03-31 | -990.71% |
| 2018-12-31 | -304.12% |
| 2018-09-30 | -169835.00% |
| 2018-06-30 | -126538.89% |
| 2018-03-31 | -147767.86% |
| 2017-12-31 | -12205.36% |
| 2017-09-30 | -7805.76% |
| 2017-06-30 | -6915.77% |
| 2017-03-31 | -6757.80% |
| 2016-12-31 | -1576.99% |
| 2016-09-30 | -1561.51% |
| 2016-06-30 | -1169.45% |
| 2016-03-31 | -1631.00% |
| 2015-12-31 | -606.73% |
| 2015-09-30 | -345.30% |
| 2015-06-30 | -774.01% |
| 2015-03-31 | 68.33% |
| 2014-12-31 | -178.27% |
| 2014-09-30 | -60.92% |
| 2014-06-30 | -54.64% |
| 2014-03-31 | -12.57% |
| 2013-12-31 | 40.55% |
| 2013-09-30 | 11.80% |
| 2013-06-30 | 12.63% |
| 2013-03-31 | 12.63% |
